Guo; Liangqin

Patent Applications and Registrations

Patent applications and USPTO patent grants for Guo; Liangqin.The latest application filed is for "4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activity in voltage-gated sodium channels".

Company Profile

13.26.33

Guo; Liangqin - Monroe NJ
Guo; Liangqin - Monroe Township NJ
Guo; Liangqin - Edison NJ US
GUO; Liangqin - Kenilworth NJ US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted [1.1.1] bicyclo compounds as indoleamine 2,3-dioxygenase inhibitors Grant 11,352,320 - He , et al. June 7, 2	2022-06-07
4-amino Or 4-alkoxy-substituted Aryl Sulfonamide Compounds With Selective Activity In Voltage-gated Sodium Channels App 20220000844 - Bungard; Christopher J. ; et al.	2022-01-06
Novel Substituted Tricyclic Compounds As Indoleamine 2,3-dioxygenase Inhibitors App 20210403469 - Han; Yongxin ; et al.	2021-12-30
Novel [1.1.1] Bicyclo Compounds as Indoleamine 2,3-Dioxygenase Inhibitors App 20210393600 - Guo; Liangqin ; et al.	2021-12-23
Novel Arylalkyl Pyrazole Compounds As Indoleamine 2,3-dioxygenase Inhibitors App 20210380572 - Clausen; Dane ; et al.	2021-12-09
Novel Aryloxypiperidine Pyrazole Compounds As Indoleamine 2,3-dioxygenase Inhibitors App 20210330676 - Clausen; Dane ; et al.	2021-10-28
Novel Substituted [1.1.1] Bicyclo Compounds As Indoleamine 2,3-dioxygenase Inhibitors App 20210198190 - He; Shuwen ; et al.	2021-07-01
Substituted N'-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase IDO inhibitors Grant 11,034,661 - Guo , et al. June 15, 2	2021-06-15
Substituted n'-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors Grant 10,988,487 - Liu , et al. April 27, 2	2021-04-27
Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels Grant 10,968,210 - Greshock , et al. April 6, 2	2021-04-06
Pcsk9 Antagonist Compounds App 20210069288 - Josien; Hubert ; et al.	2021-03-11
Substituted sulfoximine compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors Grant 10,927,086 - Liu , et al. February 23, 2	2021-02-23
Novel Substituted N'-hydroxycarbamimidoyl-1,2,5-oxadiazole Compounds As Indoleamine 2,3-dioxygenase (ido) Inhibitors App 20200231606 - Liu; Kun ; et al.	2020-07-23
Diamino-alkylamino-linked Arylsulfonamide Compounds With Selective Activity In Voltage-gated Sodium Channels App 20200131167 - Greshock; Thomas J. ; et al.	2020-04-30
Novel Substituted N'-hydroxycarbamimidoyl-1,2,5-oxadiazole Compounds As Indoleamine 2,3-dioxygenase Ido Inhibitors App 20200102278 - Guo; Liangqin ; et al.	2020-04-02
Novel Substituted Sulfoximine Compounds As Indoleamine 2,3-dioxygenase (ido) Inhibitors App 20200095212 - Liu; Kun ; et al.	2020-03-26
Compounds as indoleamine 2,3-dioxygenase inhibitors Grant 10,538,497 - Han , et al. Ja	2020-01-21
Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels Grant 10,519,147 - Greshock , et al. Dec	2019-12-31
HYDROXYALKYLAMINE- and HYDROXYCYCLOALKYLAMINE-SUBSTITUTED DIAMINE-ARYLSULFONAMIDE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-G App 20190233406 - Greshock; Thomas J. ; et al.	2019-08-01
Hydroxyalkylamine- and hydroxycycloalkylamine-substituted diamine-arylsulfonamide compounds with selective activity in voltage-gated sodium channels Grant 10,221,167 - Greshock , et al.	2019-03-05
Factor IXa inhibitors Grant 10,189,819 - Zhang , et al. Ja	2019-01-29
Novel Compounds As Indoleamine 2,3-dioxygenase Inhibitors App 20180362482 - Han; Yongxin ; et al.	2018-12-20
DIAMINO-ALKYLAMINO-Linked ARYLSULFONAMIDE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELS App 20180362518 - Greshock; Thomas J. ; et al.	2018-12-20
Factor IXa inhibitors Grant 9,914,727 - Smith , et al. March 13, 2	2018-03-13
Factor IXa Inhibitors App 20180030036 - Zhang; Ting ; et al.	2018-02-01
Factor IXa inhibitors Grant 9,708,308 - Smith , et al. July 18, 2	2017-07-18
Factor IXa inhibitors Grant 9,695,198 - Smith , et al. July 4, 2	2017-07-04
HYDROXYALKYLAMINE- and HYDROXYCYCLOALKYLAMINE-SUBSTITUTED DIAMINE-ARYLSULFONAMIDE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELS App 20170174674 - Greshock; Thomas J. ; et al.	2017-06-22
Factor IXa Inhibitors App 20150368269 - Smith; Cameron James ; et al.	2015-12-24
Factor IXa Inhibitors App 20150329562 - Smith; Cameron James ; et al.	2015-11-19
Factor IXa Inhibitors App 20150322056 - SMITH; Cameron James ; et al.	2015-11-12
Oxadiazole beta carboline derivatives as antidiabetic compounds Grant 8,754,099 - Guo , et al. June 17, 2	2014-06-17
Oxadiazole Beta Carboline Derivatives As Antidiabetic Compounds App 20120264777 - Guo; Liangqin ; et al.	2012-10-18
Triazole Beta Carboline Derivatives As Anti-diabetic Agents App 20110201615 - Guo; Liangqin ; et al.	2011-08-18
Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activity App 20100234409 - Yang; Lihu ; et al.	2010-09-16
Beta Carboline Derivatives As Antidiabetic Compounds App 20100184758 - Dobbelaar; Peter H. ; et al.	2010-07-22
Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators Grant 7,652,024 - Bakshi , et al. January 26, 2	2010-01-26
Acylated Spiropiperidine Derivatives As Melanocortin-4 Receptor Modulators App 20090325990 - Bakshi; Raman K. ; et al.	2009-12-31
Acylated Piperidine Derivatives as Melanocortin 4-Receptor Agonists App 20080051430 - Barakat; Khaled J. ; et al.	2008-02-28
Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists Grant 7,329,673 - Guo , et al. February 12, 2	2008-02-12
Bicyclic piperidine derivatives as melanocortin-4 receptor agonists Grant 7,276,520 - Nargund , et al. October 2, 2	2007-10-02
Acylated piperazine derivatives as melanocortin-4 receptor agonists Grant 7,160,886 - Bakshi , et al. January 9, 2	2007-01-09
Bridged piperidine derivatives as melanocortin receptor agonists Grant 7,115,628 - Ye , et al. October 3, 2	2006-10-03
Bicyclic piperidine derivatives as melanocortin-4 receptor agonists App 20060194780 - Nargund; Ravi P. ; et al.	2006-08-31
Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists App 20060183904 - Guo; Liangqin ; et al.	2006-08-17
Acylated piperazine derivatives as melanocortin-4 receptor agonists App 20040204398 - Bakshi, Raman K. ; et al.	2004-10-14
Bridged piperidine derivatives as melanocortin receptor agonists App 20040180923 - Ye, Zhixiong ; et al.	2004-09-16
Substituted piperidines as melanocortin receptor agonists App 20020019523 - Palucki, Brenda L. ; et al.	2002-02-14
Somatostatin agonists Grant 6,063,796 - Yang , et al. May 16, 2	2000-05-16
Somatostatin agonists Grant 6,025,372 - Yang , et al. February 15, 2	2000-02-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.